
CMC Risk Diagnostic
A focused assessment of your CMC position that identifies gaps in analytical, manufacturing, and control documentation and ranks the risks most likely to affect upcoming milestones.
Learn More about CMC Risk DiagnosticRegulatory CMC guidance for small-molecule, peptide, and oligonucleotide therapeutics, from pre-IND planning through clinical development.
Connect analytical, formulation, and manufacturing considerations with phase-appropriate regulatory CMC strategy.
Identify submission gaps, anticipate review questions, and prioritize issues that could affect development milestones.
Align technical partners, development priorities, and regulatory deliverables through focused CMC leadership.
From a focused CMC risk assessment to IND readiness and ongoing CMC leadership.

A focused assessment of your CMC position that identifies gaps in analytical, manufacturing, and control documentation and ranks the risks most likely to affect upcoming milestones.
Learn More about CMC Risk Diagnostic
Develop a phase-appropriate CMC strategy and submission package aligned with regulatory expectations and your program’s development stage.
Learn More about IND-Ready CMC System™
Ongoing regulatory CMC leadership and strategic advice as development priorities, manufacturing partners, and regulatory requirements evolve.
Learn More about CMC Leadership RetainerNexus works with emerging biotech and lean pharmaceutical teams to identify CMC risk, coordinate CDMO and laboratory partners, and prepare regulatory documentation appropriate to each stage of development.
Regulatory CMC experience across small-molecule, peptide, and oligonucleotide programs and their distinct analytical and manufacturing considerations.
Experience spanning regulatory review and pharmaceutical development shapes how we anticipate agency questions and weigh CMC risk.
Engagements are led directly by senior CMC expertise and scoped to the milestone in front of you.
Perspectives, video insights and LinkedIn articles from the Nexus team are collected on CMC Perspectives.
Current opportunities are listed on LinkedIn. We also welcome interest from experienced regulatory CMC professionals for project-based consulting engagements.
A 30-minute scoping call to review your development stage, open CMC questions, and whether Nexus is the right fit.